Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Dow
Queensland Health
UBS
Accenture
McKesson
Express Scripts
Federal Trade Commission
AstraZeneca

Generated: December 10, 2018

DrugPatentWatch Database Preview

Drug Price Trends for CEPHALEXIN

« Back to Dashboard

Drug Price Trends for CEPHALEXIN

Average Pharmacy Cost for CEPHALEXIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CEPHALEXIN 125 MG/5 ML SUSP 00093-4175-74 0.09799 ML 2018-11-21
CEPHALEXIN 125 MG/5 ML SUSP 24979-0154-14 0.11594 ML 2018-11-21
CEPHALEXIN 125 MG/5 ML SUSP 24979-0154-38 0.09799 ML 2018-11-21
CEPHALEXIN 125 MG/5 ML SUSP 42043-0142-38 0.11594 ML 2018-11-21
CEPHALEXIN 125 MG/5 ML SUSP 00093-4175-73 0.11594 ML 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for CEPHALEXIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CEPHALEXIN 250MG, USP,CAP AvKare, Inc. 42291-0208-50 500 71.10 0.14220 EA 2018-01-01 - 2022-12-31 FSS
CEPHALEXIN 500MG, USP,CAP AvKare, Inc. 42291-0209-50 500 46.95 0.09390 EA 2018-01-01 - 2022-12-31 FSS
CEPHALEXIN 500MG CAP Teva Pharmaceuticals USA, Inc. 00093-3147-05 500 83.66 0.16732 EA 2017-08-15 - 2022-08-14 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
AstraZeneca
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt
Accenture
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.